Problem statement: Answer the multiple choice question.
Query: Which drug exhibits a 8.721% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any additional words.
Options:
(a) CC1CN(CC(=O)NCc2ccc(Cl)cc2)CC(C)O1
(b) COc1ccc2c(c1)[nH]c1c(=O)n(CCN3CCOCC3)cnc12
Answer: b. COc1ccc2c(c1)[nH]c1c(=O)n(CCN3CCOCC3)cnc12
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
COc1ccc2c(c1)[nH]c1c(=O)n(CCN3CCOCC3)cnc12
COc1ccc2c(c1)[nH]c1c(=O)n(CCN3CCOCC3)cnc12
7-methoxy-3-(2-morpholin-4-ylethyl)-5H-pyrimido[5,4-b]indol-4-one